Marshall Wace’s American Renal Associates Holdings, Inc ARA Stock Holding History

Marshall Wace’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-92,039	Closed	-$684K	–	2014
2019 Q2	$684K	Buy	92,039 +80,748	+715%	+$533K	0.01%	1017
2019 Q1	$69K	Sell	11,291 -21,259	-65%	-$246K	﹤0.01%	1491
2018 Q4	$376K	Buy	+32,550	New	+$555K	﹤0.01%	1187
2016 Q3	–	Sell	-54,519	Closed	-$1.58M	–	1207
2016 Q2	$1.58M	Buy	+54,519	New	+$1.52M	0.01%	638

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Marshall Wace's ARA Position: Q3 2019 in Review

Marshall Wace sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2019, closing a stake of 92,039 shares — an estimated $684K sold.

Marshall Wace first reported a position in ARA in Q2 2016 and held it in 4 quarters. The position peaked at $1.58M in Q2 2016. 63 funds tracked by Wall St. Rank hold ARA as of Q3 2019.

Marshall Wace reported no remaining American Renal Associates Holdings, Inc position as of Q3 2019 after selling out during the quarter.
Marshall Wace sold 92,039 American Renal Associates Holdings, Inc shares in Q3 2019, an estimated $684K.
Marshall Wace first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 4 quarters.
Marshall Wace's American Renal Associates Holdings, Inc position peaked at $1.58M in Q2 2016.
63 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2019.

Based on Marshall Wace's 13F filing for Q3 2019, filed 14 Nov 2019.